IPRIPR2022-01524Institution Denied
Apotex Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 11253572.
Type
IPR
Filed
Sep 9, 2022
Instituted
Mar 10, 2023
Decided
Mar 10, 2023
Patent
Application
17352892
Inventor
George YANCOPOULOS
Granted
Feb 22, 2022
01
Timeline
3 milestones
2022-09-09Petition filed
2023-03-10Institution
2023-03-10Terminated
02
Parties & counsel
Petitioner
Apotex Inc. et al.
Counsel
Rea, Teresaet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Brausa, Adamet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →